Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment.
説明 | Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment. |
In vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
別名 | Cereblon Ligand-Linker Conjugates 10, E3LigaseLigand-LinkerConjugates24, Thalidomide-O-amido-PEG2-C2-NH2 |
分子量 | 462.459 |
分子式 | C21H26N4O8 |
CAS No. | 1957235-74-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-PEG2-C2-NH2 1957235-74-3 Thalidomide O amido PEG2 C2 NH2 Cereblon Ligand-Linker Conjugates 10 Thalidomide-O-amido-PEG-2-C2-NH2 Cereblon Ligand-Linker Conjugates 10 E3LigaseLigand-LinkerConjugates24 ThalidomideOamidoPEG2C2NH2 Inhibitor inhibitor inhibit